|
Business |
|
Solvay Pharma India (DUPHARPH) has presence in the field of women`s health, gastroenterology, mental health and influenza vaccines. It was formed as a consequence of demerger of the pharma business of Duphar-Interfran into Duphar Pharma India in 2001 and acquired its present name with effect from Sep. 09, 2002. The company is part of the Solvay group, the ultimate holding company being Solvay S.A. of Belgium, having many direct and indirect sub... More.. |
|
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2010 (12) | 31-Dec-2009 (12) | 31-Dec-2008 (12) | | Net sales | 2947.30 | 2417.26 | 2003.38 | | Other Income | 36.86 | 23.46 | 41.66 | | Total Income | 2984.16 | 2440.72 | 2045.04 | | Cost of goods sold | 2215.41 | 1815.24 | 1538.93 | | OPBDIT | 768.75 | 625.48 | 506.11 | | PAT | 508.49 | 400.28 | 328.04 | | Gross Block | - | - | - | | Equity capital | 50.50 | 50.50 | 50.50 | | EPS (Rs.) | 100.70 | 79.27 | 64.96 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | 17.38 - 35.75 | 6.56 - 24.99 | 7.10 - 10.96 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 25.8 | 25.6 | 24.7 | | Net margin (% of OI) | 17.0 | 16.4 | 16.0 |
|
|
Detailed Financials
|
|
|
|
|
